Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2021-03-04 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated March 4, 2021, addressed to stock exchanges regarding the schedule of analyst/institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an intimation about upcoming investor meetings, specifically a conference call with Macquarie Capital. There is no financial data, no detailed report, no voting results, no management changes, or other substantive content typical of financial reports. The document is brief (1769 characters) and serves as an announcement of a scheduled event rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-03-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated March 2, 2021, addressed to stock exchanges, informing about the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The content is purely an intimation of scheduled meetings (conference calls) with investors and analysts, with no financial data, report, or detailed presentation included. The document length is only 2497 characters, which is quite short and does not contain any financial statements or detailed analysis. It is an announcement of meetings rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-03-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated February 19, 2021, addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events and information. The content is about informing the stock exchanges of upcoming investor meetings and explicitly states that no unpublished price sensitive information will be shared. There are no financial statements, detailed financial data, or report attachments. The document is an announcement of a meeting schedule rather than a financial report or detailed presentation. Given the short length (1771 characters) and the nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-02-19 English
Spurt in Volume
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited regarding an increase in trading volume of the company's stock. It clarifies that there is no undisclosed price sensitive information and that all information is in the public domain, complying with SEBI regulations. The document does not contain any financial data, report, or detailed analysis. It is a regulatory communication responding to a surveillance query about stock volume, which fits the category of a general regulatory announcement or compliance communication. The document length is short (1903 characters), and it is not a report or announcement of a report publication. Therefore, it best fits the category of Regulatory Filings (RNS).
2021-02-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is about informing the exchange of upcoming investor meetings, including dates, types, and participants. There is no financial data, no report attached or referenced as being published, and no detailed financial or management discussion. The document is short (2157 characters) and serves as an announcement of scheduled meetings rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-02-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call for Q3 and 9M FY21 of Dr. Lal PathLabs. It includes management commentary, financial performance highlights, and a Q&A session with analysts. The presence of detailed financial figures, discussion of quarterly results, and management's outlook confirms this is a full transcript of an earnings call. The document is not a brief earnings release but a full transcript, which matches the definition of a Call Transcript (CT). The document length is 15,000 characters, indicating it is comprehensive and not just a short announcement or summary. Therefore, the correct classification is Call Transcript (CT).
2021-02-09 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.